Tumour progression is characterised by an imbalance between cell proliferat
ion and apoptosis. The aim of our study was to estimate the importance of p
roliferation and apoptosis associated parameters in primary squamous cell c
arcinomas (SCCs) of the oral cavity and oropharynx. For determination of ap
optosis, the enzymatic labelling of DNA fragmentation with a terminal trans
ferase reaction was used in 156 tissue samples of 107 patients, including c
orresponding lymph-node metastases in nine cases. P53, bcl-2, and Ki-67 wer
e determined immunohistologically. P53 was detectable in 50.5% of the cases
. Positive staining was associated significantly with decreased apoptosis (
P<0.003). Bcl-2 was upregulated in 31.8% of the cases depending on the tumo
ur grading (P<0.001) and correlated negatively with apoptosis (P<0.001). Pr
oliferation (P<0.006) and apoptosis (P<0.03) were enhanced in larger rumour
s, though a direct correlation between these two parameters was not proven.
Nevertheless, in contrast to the conventional tumour staging and grading,
neither the expression of p53 or bcl-2 nor the apoptosis or Ki-67 measureme
nts were able to predict survival or recurrence-free survival of the patien
ts suffering from a SCC in the oral cavity or oropharynx. Our observations
suggest that the function of wild-type p53 to induce apoptosis is lost in a
t least half of the SCCs under study and that the physiological function of
bcl-2 as potent inhibitor of apoptosis is widely preserved in oral SCC.